Obstructive Lung Diseases Completed Phase 2 Trials for PF-00610355 (DB11871)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00808288A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.Treatment